Indication:
Antithrombotic action, mediated through inhibition of platelet activation, secondary prophylaxis following myocardial infarction and unstable angina or cerebral transient ischemic attacks.
Dosage & Administration:
150 mg at diagnosis and 75 mg daily thereafter.
Preparation:
Carva® 75 tablet: Box containing 195 tablets in blister pack.
